Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Dare Bioscience Inc. develops innovative women’s health solutions, including prescription and compounded products for contraception, sexual health, menopause, and vaginal health. Its portfolio features FDA-approved XACIATO for bacterial vaginosis and pipeline candidates like Ovaprene, Sildenafil Cream, and DARE-HRT1, targeting unmet needs in fertility, VMS, and FSAD. The company leverages clinical data, strategic collaborations, and alternative pathways to bring evidence-based, first-in-category products to market.
This description was generated via AI from an annual report. Updated about 1 year ago.